163 related articles for article (PubMed ID: 34644263)
1. Cosmc transfection decreases malignant behavior of Tn
Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
[TBL] [Abstract][Full Text] [Related]
2. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.
Liu J; Xu F; Li J; Jiang H
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452513
[TBL] [Abstract][Full Text] [Related]
4. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
5. The Cosmc connection to the Tn antigen in cancer.
Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
[TBL] [Abstract][Full Text] [Related]
6. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
[TBL] [Abstract][Full Text] [Related]
7. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.
Yu X; Du Z; Sun X; Shi C; Zhang H; Hu T
Int J Clin Exp Pathol; 2015; 8(3):2590-602. PubMed ID: 26045765
[TBL] [Abstract][Full Text] [Related]
9. Cosmc is required for T cell persistence in the periphery.
Cutler CE; Jones MB; Cutler AA; Mener A; Arthur CM; Stowell SR; Cummings RD
Glycobiology; 2019 Oct; 29(11):776-788. PubMed ID: 31317176
[TBL] [Abstract][Full Text] [Related]
10. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
Liu Z; Liu J; Dong X; Hu X; Jiang Y; Li L; Du T; Yang L; Wen T; An G; Feng G
J Cell Mol Med; 2019 Mar; 23(3):2083-2092. PubMed ID: 30637914
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Sun X; Ju T; Cummings RD
BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
[TBL] [Abstract][Full Text] [Related]
13. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
Ju T; Lanneau GS; Gautam T; Wang Y; Xia B; Stowell SR; Willard MT; Wang W; Xia JY; Zuna RE; Laszik Z; Benbrook DM; Hanigan MH; Cummings RD
Cancer Res; 2008 Mar; 68(6):1636-46. PubMed ID: 18339842
[TBL] [Abstract][Full Text] [Related]
14. Cosmc is an essential chaperone for correct protein O-glycosylation.
Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
[TBL] [Abstract][Full Text] [Related]
16. Cosmc-dependent mucin-type
Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
[TBL] [Abstract][Full Text] [Related]
17. Germline
Erger F; Aryal RP; Reusch B; Matsumoto Y; Meyer R; Zeng J; Knopp C; Noel M; Muerner L; Wenzel A; Kohl S; Tschernoster N; Rappl G; Rouvet I; Schröder-Braunstein J; Seibert FS; Thiele H; Häusler MG; Weber LT; Büttner-Herold M; Elbracht M; Cummings SF; Altmüller J; Habbig S; Cummings RD; Beck BB
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2211087120. PubMed ID: 37216524
[TBL] [Abstract][Full Text] [Related]
18. CD3/CD28 dynabeads induce expression of tn antigen in human t cells accompanied by hypermethylation of the cosmc promoter.
Shi C; Xu X; Yu X; Du Z; Luan X; Liu D; Hu T
Mol Immunol; 2017 Oct; 90():98-105. PubMed ID: 28708980
[TBL] [Abstract][Full Text] [Related]
19. Functional assays for the molecular chaperone cosmc.
Ju T; Cummings RD
Methods Enzymol; 2010; 479():107-22. PubMed ID: 20816162
[TBL] [Abstract][Full Text] [Related]
20. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
